Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 60, Issue 3, 2017, Pages 809-817

  Kim, Min ^a   Nevado Holgado, Alejo ^b   Whiley, Luke ^a,l   Snowden, Stuart G ^a   Soininen, Hilkka ^c   Kloszewska, Iwona ^d   Mecocci, Patrizia ^e   Tsolaki, Magda ^f   Vellas, Bruno ^g   Thambisetty, Madhav ^h   Dobson, Richard J B ⁱ   Powell, John F ⁱ   Lupton, Michelle K ^j   Simmons, Andy ^i,k   Velayudhan, Latha ⁱ   Lovestone, Simon ^b   Proitsi, Petroula ⁱ   Legido Quigley, Cristina ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

^e UNIVERSITY OF PERUGIA   (Italy)

^f ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^g Faculté de Médecine Centre Hospitalo universitaire   (France)

^h NATIONAL INSTITUTE ON AGING   (United States)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^k SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Alzheimers disease; brain atrophy; ceramide; phosphatidylcholine

Indexed keywords

CERAMIDE; EDETIC ACID; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CHOLESTEROL LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIPPOCAMPUS; HUMAN; LIPID LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TOTAL CHOLESTEROL LEVEL; TRIACYLGLYCEROL LEVEL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; AGE; ATROPHY; BLOOD; DIAGNOSTIC IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOLOGY;

AGE FACTORS; AGED; ALZHEIMER DISEASE; ATROPHY; BIOMARKERS; CERAMIDES; CROSS-SECTIONAL STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; PHOSPHATIDYLCHOLINES;

EID: 85030635122     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160645     Document Type: Article

References (37)

1. Alzheimer's, Association (2015) 2015 Alzheimer's disease facts and figures. Alzheimers Dement 11, 332-384.
2. Hebert LE, Weuve J, Scherr PA, Evans DA (2013) Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80, 1778-1783.
3. Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20, 415-418.
4. Sato Y, Nakamura T, Aoshima K, Oda Y (2010) Quantitative and wide-ranging profiling of phospholipids in human plasma by two-dimensional liquid chromatography/mass spectrometry. Anal Chem 82, 9858-9864.
5. Han X, Rozen S, Boyle SH, Hellegers C, Cheng H, Burke JR,Welsh-Bohmer KA, Doraiswamy PM, Kaddurah-Daouk R (2011) Metabolomics in early Alzheimer's disease: Identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One 6, e21643.
6. Trushina E, Mielke MM (2014) Recent advances in the application of metabolomics to Alzheimer's disease. Biochim Biophys Acta 1842, 1232-1239.
7. Satoi H, Tomimoto H, Ohtani R, Kitano T, Kondo T, Watanabe M, Oka N, Akiguchi I, Furuya S, Hirabayashi Y, Okazaki T (2005) Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis. Neuroscience 130, 657-666.
8. Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A 101, 2070-2075.
9. Mielke MM, Bandaru VV, Haughey NJ, Xia J, Fried LP, Yasar S, Albert M,VarmaV, Harris G, Schneider EB, Rabins PV, Bandeen-Roche K, Lyketsos CG, Carlson MC (2012) Serum ceramides increase the risk of Alzheimer disease: The Women's Health and Aging Study II. Neurology 79, 633-641.
10. Whiley L, Sen A, Heaton J, Proitsi P, Garcia-Gomez D, Leung R, Smith N, Thambisetty M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Lovestone S, Legido-Quigley C, AddNeuroMed Consortium (2014) Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. Neurobiol Aging 35, 271-278.
11. Casanova R,Varma S, Simpson B, Kim M, AnY, Saldana S, Riveros C, Moscato P, Griswold M, Sonntag D,Wahrheit J, Klavins K, Jonsson PV, Eiriksdottir G, Aspelund T, Launer LJ, Gudnason V, Quigley CL, ThambisettyM(2016) Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals. Alzheimers Dement 12, 815-822.
12. Proitsi P, Kim M, Whiley L, Pritchard M, Leung R, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Sham P, Lovestone S, Powell JF, Dobson RJ, Legido-Quigley C (2015) Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease. Transl Psychiatry 5, e494.
13. Proitsi P, Kim M, Whiley L, Simmons A, Sattlecker M, Velayudhan L, Lupton MK, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Powell JF, Dobson RJ, Legido-Quigley C (2016) Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis. Alzheimers Dement, doi: 10.1016/j.jalz.2016.08.003
14. Lovestone S, Francis P, Strandgaard K (2007) Biomarkers for disease modification trials\-The innovative medicines initiative and AddNeuroMed. J Nutr Health Aging 11, 359-361.
15. Whiley L, Godzien J, Ruperez FJ, Legido-Quigley C, Barbas C (2012) In-vial dual extraction for direct LCMS analysis of plasma for comprehensive and highly reproducible metabolic fingerprinting. Anal Chem 84, 5992-5999.
16. Astarita G, Jung KM, Vasilevko V, Dipatrizio NV, Martin SK, Cribbs DH, Head E, Cotman CW, Piomelli D (2011) Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease. PLoS One 6, e24777.
17. Chan RB, Oliveira TG, Cortes EP, Honig LS, Duff KE, Small SA, Wenk MR, Shui G, Di Paolo G (2012) Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J Biol Chem 287, 2678-2688.
18. Engelborghs S, Maertens K, Vloeberghs E, Aerts T, Somers N, Marien P, De Deyn PP (2006) Neuropsychological and behavioural correlates of CSF biomarkers in dementia. Neurochem Int 48, 286-295.
19. Kester MI, Goos JDC, Teunissen CE, Benedictus MR, Bouwman FH, Wattjes MP, Barkhof F, Scheltens P, van der Flier WM (2014) Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. JAMA Neurol 71, 855-862.
20. Filippov V, Song MA, Zhang KL, Vinters HV, Tung S, Kirsch WM, Yang J, Duerksen-Hughes PJ (2012) Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. J Alzheimers Dis 29, 537-547.
21. Malaplate-Armand C, Florent-Bechard S, Youssef I, Koziel V, Sponne I, Kriem B, Leininger-Muller B, Olivier JL, Oster T, Pillot T (2006) Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis 23, 178-189.
22. Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4, 604-616.
23. Ellis B, Hye A, Snowden SG (2015) Metabolic modifications in human biofluids suggest the involvement of sphingolipid, antioxidant, and glutamate metabolism in Alzheimer's disease pathogenesis. J Alzheimers Dis 46, 313-327.
24. Morad SAF, Cabot MC (2013) Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 13, 51-65.
25. Puglielli L, Ellis BC, Saunders AJ, Kovacs DM (2003) Ceramide stabilizes beta-site amyloid precursor proteincleaving enzyme 1 and promotes amyloid beta-peptide biogenesis. J Biol Chem 278, 19777-19783.
26. Swerdlow RH (2007) Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Neurobiol Aging 28, 1465-1480.
27. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol 12, 207-216.
28. MielkeMM, Haughey NJ, Bandaru VVR, Schech S, Carrick R, Carlson MC, Mori S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG (2010) Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers Dement 6, 378-385.
29. Simpson BN, Kim M, Chuang Y-F, Beason-Held L, Kitner-Triolo M, Kraut M, Lirette ST,Windham BG, Griswold ME, Legido-Quigley C, Thambisetty M (2016) Blood metabolite markers of cognitive performance and brain function in aging. J Cereb Blood Flow Metab 36, 1212-1223.
30. Fitzpatrick AL, Irizarry MC, Cushman M, Jenny NS, Chi GC, Koro C (2014) Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study. Atherosclerosis 235, 384-391.
31. Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X,Wenk MR, Goh EL, Silver DL (2014) Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 509, 503-506.
32. Morris MC, Tangney CC,Wang Y, Sacks FM, Bennett DA, Aggarwal NT (2015) MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement 11, 1007-1014.
33. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, Lawlor B, Coakley D, Gibney MJ (2003) Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: A case-control study. Br J Nutr 89, 483-489.
34. Kidd PM (2007) Omega-3 DHA and EPA for cognition, behavior, and mood: Clinical findings and structuralfunctional synergies with cell membrane phospholipids. Altern Med Rev 12, 207-227.
35. Yu Z, Zhai G, Singmann P, He Y, Xu T, Prehn C, Romisch-MarglW, Lattka E, Gieger C, Soranzo N, Heinrich J, Standl M, Thiering E, Mittelstrass K, Wichmann HE, Peters A, Suhre K, Li Y, Adamski J, Spector TD, Illig T, Wang-Sattler R (2012) Human serum metabolic profiles are age dependent. Aging Cell 11, 960-967.
36. Das U (2011) Essential fatty acids-biochemistry, physiology and clinical significance. In Molecular Basis of Health and Disease, Springer, Netherlands, pp. 101-151.
37. Di Marzo V, Stella N, Zimmer A (2015) Endocannabinoid signalling and the deteriorating brain. Nat Rev Neurosci 16, 30-42.